Speqta - Exciting Times Ahead
2021-05-31 11:00:00
Redeye reiterates its positive view of Speqta, after a quarter with revenues that were in line with our estimates but with considerably stronger margins, primarily in the C&C segment. Although the pandemic is currently causing challenges, we deem these temporary and expect Speqta to be a clear post-Covid-19 winner. Moreover, Bidbrain is set to be launched in Q2, and the combination should put Speqta back on its strong growth path.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/